ATAZANAVIR + COBICISTAT

atazanavir 300 mg + cobicistat 150 mg tablet, 30

ATAZANAVIR + COBICISTAT (10692R)

atazanavir 300 mg + cobicistat 150 mg tablet, 30
10692R
Body System:
Manner of administration:Oral
S100 HSD Community Access
Authority Required (STREAMLINED)

Restriction  4512

Indication: HIV infection
Treatment phase: Initial

Restriction  4454

Indication: HIV infection
Treatment phase: Continuing
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 60 # of repeats: 5 DPMQ: $714.68 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Evotaz